Precipitation of Congestive Heart Failure: Social and Emotional Factors

Perlman, Lawrence V.

doi:10.7326/0003-4819-75-1-1

Cited by 46 publications

(24 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Depression, hopelessness, and anxiety have been shown to adversely affect the course and outcome of cancers in several recent studies (48)(49)(50)(51)(52)(53). Similar findings have been reported for cardiac patients (54) and for patients with congestive heart failure (29). These course and outcome studies are implemented more easily and at less expense than studies on etiology and onset.…”

Section: Implica Nons and Conclusionsupporting

confidence: 56%

See 1 more Smart Citation

The Relation of Psychological Stress to Onset of Medical Illness

Hurst¹,

Jenkins²,

Rose³

1976

Annu. Rev. Med.

View full text Add to dashboard Cite

Section: Implica Nons and Conclusionsupporting

confidence: 56%

“…Perlman et al (29) noted four studies examining the relationship between emo tional factors and the onset of congestive heart failure. Two studies seemed to indicate a strong emotional precipitating factor and two did not.…”

Section: Life Event Studiesmentioning

confidence: 98%

The Relation of Psychological Stress to Onset of Medical Illness

Hurst¹,

Jenkins²,

Rose³

1976

Annu. Rev. Med.

View full text Add to dashboard Cite

“…Mental stress and depression also precipitate worsening of established HF. 42,103,104 Systemic biomarkers may indicate the risk of development of HF. Microalbuminuria, defined as an albumin/creatinine ratio of 2 mg/mmol, is associated with a 3-fold increase in the risk of hospitalization for HF, and every 0.4-mg/mmol increase in the albumin/creatinine ratio is associated with a Ͼ10% increase in worsening of HF.…”

Section: Minor Clinical Risk Factorsmentioning

confidence: 99%

Prevention of Heart Failure

et al. 2008

View full text Add to dashboard Cite

Abstract-The increase in heart failure (HF) rates throughout the developed and developing regions of the world poses enormous challenges for caregivers, researchers, and policymakers. Therefore, prevention of this global scourge deserves high priority. Identifying and preventing the well-recognized illnesses that lead to HF, including hypertension and coronary heart disease, should be paramount among the approaches to prevent HF. Aggressive implementation of evidence-based management of risk factors for coronary heart disease should be at the core of HF prevention strategies.Questions currently in need of attention include how to identify and treat patients with asymptomatic left ventricular systolic dysfunction (Stage B HF) and how to prevent its development. The relationship of chronic kidney disease to HF and control of chronic kidney disease in prevention of HF need further investigation. Currently, we have limited understanding of the pathophysiological basis of HF in patients with preserved left ventricular systolic function and management techniques to prevent it. New developments in the field of biomarker identification have opened possibilities for the early detection of individuals at risk for developing HF (Stage A HF). Patient groups meriting special interest include the elderly, women, and ethnic/racial minorities. Future research ought to focus on obtaining a much better knowledge of genetics and HF, especially both genetic risk factors for development of HF and genetic markers as tools to guide prevention. Lastly, a national awareness campaign should be created and implemented to increase public awareness of HF and the importance of its prevention. Heightened public awareness will provide a platform for advocacy to create national research programs and healthcare policies dedicated to the prevention of HF. (Circulation. 2008;117:2544-2565.) Key Words: AHA Scientific Statements Ⅲ heart failure Ⅲ prevention Ⅲ left ventricular dysfunction Ⅲ genetics Ⅲ awareness T he prevention of heart failure (HF) is an urgent public health need with national and global implications. According to the American Heart Association, an estimated 550 000 new cases occur each year. 1 More than 5 million Americans have HF. Among Medicare beneficiaries, HF is the leading cause of hospitalization. In 2007, the American Heart Association estimates that Ͼ$33 billion was spent on HF. 1 The syndrome of HF poses many challenges. Because of the complexity of its many causes and pathophysiological origins, HF may escape a unifying definition. From many The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement was approved by the Ame...

show abstract

“…Is there maintenance of self-control, self-re liance. and use of denial [ 13] or other coping behaviors? Are there appropriate expecta tions and optimism about the future?…”

Section: The Patient With Severe Symptomatic Congestive Heart Failurementioning

confidence: 99%

Quality of Life: Can It and Should It Be Assessed in Patients with Heart Failure?

Wenger¹

1989

Cardiology

View full text Add to dashboard Cite

The goal of therapy in patients with severe symptomatic heart failure is improvement in symptoms, stabilization or improvement in functional abilities, and improved comfort for the remaining duration of life. Prolongation of survival without these benefits appears less desirable. There is poor correlation among hemodynamic features (including ejection fraction), exercise capacity, and quality of life attributes. Patients value as an outcome of therapy quality of life attributes: comfort, sense of well-being, and physical and other functional capabilities. By contrast, patients with asymptomatic ventricular dysfunction cannot anticipate any short-term benefit of therapy, whose goal is solely improvement in long-term survival. Interference by therapy with any aspect of life quality is likely to adversely affect compliance and thereby limit long-term outcome advantages.

show abstract

Precipitation of Congestive Heart Failure: Social and Emotional Factors

Cited by 46 publications

References 13 publications

The Relation of Psychological Stress to Onset of Medical Illness

The Relation of Psychological Stress to Onset of Medical Illness

Prevention of Heart Failure

Quality of Life: Can It and Should It Be Assessed in Patients with Heart Failure?

Contact Info

Product

Resources

About